Evidence map›Paper›PMID 15004729›Full record

ArticleEuropean biophysics journal : EBJ2004

Phospholipid metabolism is required for M1 muscarinic inhibition of N-type calcium current in sympathetic neurons.

Liwang Liu, Mandy L Roberts, Ann R Rittenhouse

Abstract read
PubMed Publisher
In one paragraph

Article in European biophysics journal : EBJ, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Modulation of CaBMC research notes · 2018
    Article
  2. Article
  3. Review
  4. Article
  5. Phosphoinositides regulate ion channels.Biochimica et biophysica acta · 2015
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular reconstruction of mGluR5a-mediated endocannabinoid signaling cascade in single rat sympathetic neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. M1 muscarinic receptors inhibit L-type Ca2+ current and M-current by divergent signal transduction cascades.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liwang LiuDepartment of Physiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Mandy L Roberts
Ann R Rittenhouse
University of Massachusetts Chan Medical School · US

Funding

Plasticity N-Type Ca2+ Channels in Sympathetic NeuronsR01NS034195 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RITTENHOUSE, ANN R. · 2001 to 2005
$1.5M
CA2+ CHANNELS IN SYMPATHETIC NEURONSR29NS034195 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RITTENHOUSE, ANN R. · 1995 to 1999
–
NINDS NIH HHS NS34195
6 · The paper itself

Abstract

The signal transduction cascade mediating muscarinic receptor modulation of N-type Ca2+ channel activity by the slow pathway has remained incompletely characterized despite focused investigation. Recently we confirmed a role for the G-protein Gq and identified phospholipase C (PLC), phospholipase A2 (PLA2), and arachidonic acid (AA) as additional molecules involved in N-current inhibition in superior cervical ganglion (SCG) neurons by the slow pathway. We have further characterized this signal transduction cascade by testing whether additional molecules downstream of phosphatidylinositol-4,5-bisphosphate (PIP2) are required. The L-channel antagonist nimodipine was bath-applied to block L-current. Pretreating cells with pertussis toxin (PTX) minimized M2/M4 muscarinic receptor inhibition of N-current by the membrane-delimited pathway. Consistent with our previous studies, pharmacologically antagonizing M1 muscarinic receptors (M1Rs), Gqalpha, PLC, PLA2, and AA minimized N-current inhibition by the muscarinic agonist oxotremorine-M (Oxo-M). When cells were left untreated with PTX, leaving the membrane-delimited pathway intact and the same antagonists retested, Oxo-M decreased whole cell currents. Moreover, inhibited currents displayed slowed activation kinetics, indicating intact N-current inhibition by the membrane-delimited pathway. These findings indicate that the antagonists used to block the slow pathway acted selectively. PLA2 cleaves AA from phospholipids, generating additional metabolites. We tested whether the metabolite lysophosphatidic acid (LPA) mimicked the inhibitory actions of Oxo-M. In contrast to AA, applying LPA did not inhibit whole cell currents. Taken together, these findings suggest that the slow pathway requires M1Rs, Gqalpha, PLC, PIP2, PLA2, and AA for N-current inhibition.

Indexed as

AnimalsArachidonic AcidCalcium Channels, N-TypeElectrophysiologyGTP-Binding ProteinsKineticsLysophospholipidsMuscarinic AgonistsNeuronsOxotremorinePertussis ToxinPhospholipasesPhospholipidsRatsRats, Sprague-DawleyReceptor, Muscarinic M1Arachidonic AcidCalcium Channels, N-TypeGTP-Binding Proteinslysophosphatidic acidLysophospholipidsMuscarinic AgonistsOxotremorineoxotremorine MPertussis ToxinPhospholipasesPhospholipidsReceptor, Muscarinic M1

Identifiers

PMID15004729
OpenAlexW2009928298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.